ストックスクリーナーアプリを入手
404.58
1.89%
-7.80
アフターアワーズ：
404.58
前日終値:
$412.38
開ける：
$412.62
24時間の取引高:
948.11K
Relative Volume:
0.61
時価総額：
$92.63B
収益：
$183.12B
当期純損益:
$5.92B
株価収益率:
15.79
EPS:
25.63
ネットキャッシュフロー:
$3.67B
1週間 パフォーマンス:
-1.32%
1か月 パフォーマンス:
-7.14%
6か月 パフォーマンス:
-4.27%
1年 パフォーマンス:
-24.88%
1日の値動き範囲:
$402.11
$413.67
1週間の範囲:
$402.11
$419.99
52週間の値動き範囲:
$362.21
$567.26
Elevance Health Inc Stock (ELV) Company Profile
名前
Elevance Health Inc
セクター
電話
(800) 331-1476
住所
220 VIRGINIA AVENUE, INDIANAPOLIS
ELV を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ELV
Elevance Health Inc
|
404.58 | 92.63B | 183.12B | 5.92B | 3.67B | 25.63 |
|
UNH
Unitedhealth Group Inc
|
380.64 | 364.02B | 410.06B | 22.11B | 24.86B | 23.88 |
|
CI
Cigna Group
|
333.46 | 89.43B | 254.47B | 5.03B | 6.01B | 18.06 |
|
CVS
Cvs Health Corp
|
66.97 | 85.34B | 378.96B | 5.28B | 5.94B | 4.19 |
|
HUM
Humana Inc
|
249.53 | 31.20B | 117.76B | 1.21B | 2.39B | 9.95 |
Elevance Health Inc Stock (ELV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-15 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2025-03-17 | アップグレード | Argus | Hold → Buy |
| 2025-01-22 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2024-10-18 | ダウングレード | Argus | Buy → Hold |
| 2024-07-18 | ダウングレード | BofA Securities | Buy → Neutral |
| 2024-06-24 | 開始されました | Morgan Stanley | Overweight |
| 2024-05-30 | 開始されました | Robert W. Baird | Outperform |
| 2024-03-06 | 開始されました | Barclays | Overweight |
| 2023-07-12 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2023-04-27 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-21 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-03-28 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-09-09 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-08-22 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
すべてを表示
Elevance Health Inc (ELV) 最新ニュース
These 4 Measures Indicate That Elevance Health (NYSE:ELV) Is Using Debt Reasonably Well - Yahoo Finance
Elevance Health, Inc. (ELV): Among the Cheap ESG Stocks to Buy According to Hedge Funds - Insider Monkey
The DOJ files a lawsuit against Elevance Health, Humana and Aetna. - Benzinga
Investors Met With Slowing Returns on Capital At Elevance Health (NYSE:ELV) - Yahoo Finance
US accuses health insurers, brokers of Medicare Advantage kickback scheme - Reuters
Here's How Much $1000 Invested In Elevance Health 20 Years Ago Would Be Worth Today - Benzinga
US Claims Medicare Insurers, Brokers Used Illegal Kickbacks - Yahoo Finance
DOJ accuses health insurance giants of role in Medicare kickback scheme - Cleveland.com
Justice Department hits Aetna, Humana, Elevance Health with Medicare Advantage kickback complaint - Fierce Healthcare
Elevance Health Insiders Sell US$6.9m Of Stock, Possibly Signalling Caution - Yahoo Finance
Inova and Anthem Announce New Contract for Virginians - Business Wire
Elevance Health, Inc. (ELV): Among the Best Stocks to Buy According to D1 Capital’s Daniel Sundheim - Insider Monkey
Elevance Curbs Online Medicare Sign-Ups as Expenses Rise (ELV) - Bloomberg
Mental health network misled policyholders about provider options, lawsuit claims - Reuters
Elevance Nurses Say Their Right To OT Is Beyond Dispute - Law360
Let’s talk tariffs, and no Amazon Prime subscription with your MA plan - statnews.com
Elevance Health to slash Medicare Advantage marketing - Modern Healthcare
Is Elevance (ELV) an Attractively Valued Stock? - MSN
Elevance Health’s MLR Beat Encourages Worried Wall Street - AIS Health
Argus Adjusts Price Target on Elevance Health to $465 From $450 - marketscreener.com
‘Medicaid to the Rescue,’ Says Wall St. Analyst About Elevance Health (ELV) Stock - markets.businessinsider.com
Elevance Health (ELV) Gets a Buy from Barclays - The Globe and Mail
Elevance Health: Carelon Growth, Not Fully Appreciated (NYSE:ELV) - Seeking Alpha
Elevance health projects $34.15-$34.85 EPS for 2025 with focus on Carelon expansion - MSN
Deutsche Bank Cuts Elevance Health Price Target to $463 From $465, Maintains Buy Rating - marketscreener.com
Jefferies Adjusts Price Target on Elevance Health to $488 From $461, Maintains Buy Rating - marketscreener.com
Cantor maintains Elevance stock with $485 target, Overweight rating - Investing.com
Why Elevance Health, Inc. (ELV) is Among the Best Stocks That Will Always Grow - Yahoo Finance
Elevance Health (ELV) Maintains Dividend, Affirms 2025 Outlook - GuruFocus
Elevance Health Inc. (NYSE:ELV) Q1 2025 Earnings Call Transcript - Insider Monkey
Barclays Increases Price Target for Elevance Health (ELV) to $52 - GuruFocus
Elevance Health Inc (ELV) Q1 2025 Earnings Call Highlights: Strong EPS Growth and Strategic ... - Yahoo Finance
Elevance Health Inc (ELV) Q1 2025 Earnings Call Highlights: Strong EPS Growth and Strategic ... By GuruFocus - Investing.com Canada
Elevance Health Inc (ELV) Q1 2025 Earnings Call Highlights: Strong EPS Growth and Strategic Expansions - GuruFocus
Elevance Health: Q1 Earnings Snapshot - CT Insider
Elevance Health Reports Strong Q1 2025 Results - TipRanks
Elevance dodges high MA medical costs that sunk United - Healthcare Brew
Elevance Health Q1 2025 Earnings Call Highlights - TipRanks
Despite Medicaid pressures, Elevance reports strong Q1 earnings - InsuranceNewsNet
Elevance Health's Q1 Earnings Beat Estimates on Rising Premiums - Yahoo Finance
Elevance Health, Inc. SEC 10-Q Report - TradingView
Elevance Health execs seek to ease Wall Street's concerns about elevated MA costs - Fierce Healthcare
Elevance Health (ELV) Q1 2025 Earnings Report Highlights Growth - GuruFocus
Elevance Health Inc (ELV) Shares Down 4.72% on Apr 21 - GuruFocus
Barclays Adjusts Elevance Health Price Target to $522 From $512, Keeps Overweight Rating - marketscreener.com
Elevance says healthcare demand tracks expectations after UnitedHealth's forecast cut - marketscreener.com
Despite Medicaid Pressure, Elevance Health Delivers Strong Q1 Performance, Reiterates Profit Outlook - Yahoo Finance
Elevance Health beats Q1 expectations, reaffirms 2025 outlook - Investing.com
Elevance reports lower-than-expected medical costs, confirms profit beat - Reuters
Earnings call transcript: Elevance Health Q1 2025 beats EPS forecast - Investing.com
Is Elevance Health (ELV) The Top Falling Stock with Unusual Volume? - MSN
Elevance Health Inc (ELV) 財務データ
収益
当期純利益
現金流量
EPS
0.11%
1.30%
大文字化:
|
ボリューム (24 時間):